Cranial nerve disorders encompass a spectrum of prevalent clinical conditions, including hemifacial spasm, trigeminal neuralgia, peripheral facial paralysis and its sequelae, oculomotor nerve palsy, abducens nerve palsy, glossopharyngeal neuralgia, post-herpetic neuralgia following herpes zoster infection, as well as schwannomas originating from cranial nerves. In recent years, there has been significant progress in surgical technologies and concepts for related diseases; however, the global dissemination of these advancements and their varying efficacy across different centers underscore the critical imperative to expedite their widespread adoption through scholarly journal publications, ultimately benefiting patients. The present issue is dedicated to the advancements in surgical technology for common cranial nerve diseases, with a particular emphasis on the introduction of novel tactics and the comprehensive evaluation of their clinical application outcomes. This serves to underscore both the pioneering nature and clinical significance of this content. Priority will be given to those prospective randomized clinical studies conducted in this field.
Enhanced innovation and improved efficacy of surgical technology for the aforementioned prevalent cranial nerve disorders are crucial areas of focus. It is important to establish state-of-the-art surgical approaches, conduct a comprehensive analysis of their clinical application, and summarize prospective randomized clinical research findings pertaining to innovative surgical interventions. For instance, prospective randomized clinical studies have made significant contributions by demonstrating the efficacy of combined transplantation in treating peripheral facial palsy and neurolysis in managing sequelae of spastic facial palsy. Additionally, decompression and transplantation have shown beneficial effects in cases involving oculomotor and abducent nerve palsies.
Cranial nerve disorders encompass a spectrum of prevalent clinical conditions, including hemifacial spasm, trigeminal neuralgia, peripheral facial paralysis and its sequelae, oculomotor nerve palsy, abducens nerve palsy, glossopharyngeal neuralgia, post-herpetic neuralgia following herpes zoster infection, as well as schwannomas originating from cranial nerves. In recent years, there has been significant progress in surgical technologies and concepts for related diseases; however, the global dissemination of these advancements and their varying efficacy across different centers underscore the critical imperative to expedite their widespread adoption through scholarly journal publications, ultimately benefiting patients. The present issue is dedicated to the advancements in surgical technology for common cranial nerve diseases, with a particular emphasis on the introduction of novel tactics and the comprehensive evaluation of their clinical application outcomes. This serves to underscore both the pioneering nature and clinical significance of this content. Priority will be given to those prospective randomized clinical studies conducted in this field.
Enhanced innovation and improved efficacy of surgical technology for the aforementioned prevalent cranial nerve disorders are crucial areas of focus. It is important to establish state-of-the-art surgical approaches, conduct a comprehensive analysis of their clinical application, and summarize prospective randomized clinical research findings pertaining to innovative surgical interventions. For instance, prospective randomized clinical studies have made significant contributions by demonstrating the efficacy of combined transplantation in treating peripheral facial palsy and neurolysis in managing sequelae of spastic facial palsy. Additionally, decompression and transplantation have shown beneficial effects in cases involving oculomotor and abducent nerve palsies.